Loading...

4sc AG

VSC.DE•XETRA
Healthcare
Biotechnology
€2.98
€0.00(0.00%)

4sc AG (VSC.DE) Stock Overview

Explore 4sc AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap150.7M
P/E Ratio-3.66
EPS (TTM)$-0.41
ROE-0.90%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

VSC.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of 4sc AG (VSC.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.66 and a market capitalization of 150.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;